CoChat

A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer

Open access
Kloosterman, Wigard P., Coebergh van den Braak, Robert R.J., Pieterse, Mark, van Roosmalen, Markus J., Sieuwerts, Anieta M., Stangl, Christina, Brunekreef, Ronne, Lalmahomed, Zarina S., Ooft, Salo, van Galen, Anne, Smid, Marcel, Lefebvre, Armel, Zwartkruis, Fried, Martens, John W.M., Foekens, John A., Biermann, Katharina, Koudijs, Marco J., Ijzermans, Jan N.M., Voest, Emile E. · 2017 · Cancer Research
Cited by 94

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Genomic rearrangements that give rise to oncogenic gene fusions can offer actionable targets for cancer therapy. Here we present a systematic analysis of oncogenic gene fusions among a clinically well-characterized, prospectively collected set of 278 primary colon cancers spanning diverse tumor stages and clinical outcomes. Gene fusions and somatic genetic variations were identified in fresh frozen clinical specimens by Illumina RNA-sequencing, the STAR fusion gene detection pipeline, and GATK RNA-seq variant calling. We considered gene fusions to be pathogenically relevant when recurrent, producing divergent gene expression (outlier analysis), or as functionally important (e.g., kinase fusions). Overall, 2.5% of all specimens were defined as harboring a relevant gene fusion (kinase fusions 1.8%). Novel configurations of BRAF, NTRK3, and RET gene fusions resulting from chromosomal translocations were identified. An R-spondin fusion was found in only one tumor (0.35%), much less than an earlier reported frequency of 10% in colorectal cancers. We also found a novel fusion involving USP9X-ERAS formed by chromothripsis and leading to high expression of ERAS, a constitutively active RAS protein normally expressed only in embryonic stem cells. This USP9X–ERAS fusion appeared highly oncogenic on the basis of its ability to activate AKT signaling. Oncogenic fusions were identified only in lymph node–negative tumors that lacked BRAF or KRAS mutations. In summary, we identified several novel oncogenic gene fusions in colorectal cancer that may drive malignant development and offer new targets for personalized therapy. Cancer Res; 77(14); 3814–22. ©2017 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-16-3563

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 94

Metadata

Authors
Kloosterman, W. P., Coebergh van den Braak, R. R. J., Pieterse, M., van Roosmalen, M. J., Sieuwerts, A. M., Stangl, C., Brunekreef, R., Lalmahomed, Z. S., Ooft, S., van Galen, A., Smid, M., Lefebvre, A., Zwartkruis, F., Martens, J. W. M., Foekens, J. A., Biermann, K., Koudijs, M. J., Ijzermans, J. N. M., & Voest, E. E.
Venue
Cancer Research
Published
2017-07-13
Volume
77
Issue
14
Pages
3814-3822
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2616119389
Cited by
94
References
10
FWCI
3.85
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-16-3563
The paper
Kloosterman, W. P., Coebergh van den Braak, R. R. J., Pieterse, M., van Roosmalen, M. J., Sieuwerts, A. M., Stangl, C., Brunekreef, R., Lalmahomed, Z. S., Ooft, S., van Galen, A., Smid, M., Lefebvre, A., Zwartkruis, F., Martens, J. W. M., Foekens, J. A., Biermann, K., Koudijs, M. J., Ijzermans, J. N. M., & Voest, E. E. (2017). A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-16-3563

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.